[{"address1": "10628 Science Center Drive", "address2": "Suite 250", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 900 2660", "website": "https://arcturusrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.", "fullTimeEmployees": 174, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph E. Payne M.Sc.", "age": 52, "title": "Founder, President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 906500, "exercisedValue": 0, "unexercisedValue": 5381721}, {"maxAge": 1, "name": "Dr. Padmanabh  Chivukula Ph.D.", "age": 45, "title": "Founder, Chief Scientific Officer, COO & Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 687500, "exercisedValue": 0, "unexercisedValue": 4401638}, {"maxAge": 1, "name": "Mr. Andrew H. Sassine MBA", "age": 60, "title": "CFO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 687500, "exercisedValue": 0, "unexercisedValue": 5663780}, {"maxAge": 1, "name": "Mr. Lance  Kurata", "title": "Chief Legal Officer", "fiscalYear": 2023, "totalPay": 600000, "exercisedValue": 0, "unexercisedValue": 456563}, {"maxAge": 1, "name": "Ms. Neda  Safarzadeh", "title": "Vice President and Head of IR/PR & Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Natasha O. Bowman", "title": "Chief Human Resources Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin T. Skol", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Juergen  Froehlich FCPh, M.D., MBA", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Igor  Smolenov M.D., Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Roberta  Duncan", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 6, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.3, "open": 10.3, "dayLow": 10.11, "dayHigh": 10.66, "regularMarketPreviousClose": 10.3, "regularMarketOpen": 10.3, "regularMarketDayLow": 10.11, "regularMarketDayHigh": 10.66, "payoutRatio": 0.0, "beta": 3.414, "forwardPE": -4.721973, "volume": 358078, "regularMarketVolume": 358078, "averageVolume": 436995, "averageVolume10days": 481500, "averageDailyVolume10Day": 481500, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 285571488, "fiftyTwoWeekLow": 8.04, "fiftyTwoWeekHigh": 45.0, "priceToSalesTrailing12Months": 1.8749359, "fiftyDayAverage": 13.6242, "twoHundredDayAverage": 18.14675, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 77093736, "profitMargins": -0.53142, "floatShares": 24834707, "sharesOutstanding": 27119800, "sharesShort": 4647257, "sharesShortPriorMonth": 4189900, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.1714, "heldPercentInsiders": 0.08448, "heldPercentInstitutions": 0.92671996, "shortRatio": 11.6, "shortPercentOfFloat": 0.2685, "impliedSharesOutstanding": 27119800, "bookValue": 8.893, "priceToBook": 1.1840774, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -80941000, "trailingEps": -3.0, "forwardEps": -2.23, "lastSplitFactor": "1:7", "lastSplitDate": 1510790400, "enterpriseToRevenue": 0.506, "enterpriseToEbitda": -0.837, "52WeekChange": -0.61086476, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 10.53, "targetHighPrice": 140.0, "targetLowPrice": 44.0, "targetMeanPrice": 70.301, "targetMedianPrice": 61.5, "recommendationMean": 1.27273, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 237028000, "totalCashPerShare": 8.74, "ebitda": -92125000, "totalDebt": 28550000, "quickRatio": 3.68, "currentRatio": 4.672, "totalRevenue": 152310000, "debtToEquity": 11.848, "revenuePerShare": 5.641, "returnOnAssets": -0.15461001, "returnOnEquity": -0.31162, "grossProfits": -42846000, "freeCashflow": -9018125, "operatingCashflow": -59747000, "revenueGrowth": -0.262, "grossMargins": -0.28131, "ebitdaMargins": -0.60485, "operatingMargins": -1.46684, "financialCurrency": "USD", "symbol": "ARCT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.2330053, "regularMarketPrice": 10.53, "marketState": "CLOSED", "shortName": "Arcturus Therapeutics Holdings ", "longName": "Arcturus Therapeutics Holdings Inc.", "earningsTimestamp": 1741294860, "earningsTimestampStart": 1746529140, "earningsTimestampEnd": 1747051200, "earningsCallTimestampStart": 1741296600, "earningsCallTimestampEnd": 1741296600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.0, "epsForward": -2.23, "epsCurrentYear": -5.048, "priceEpsCurrentYear": -2.0859747, "fiftyDayAverageChange": -3.0942001, "fiftyDayAverageChangePercent": -0.2271106, "twoHundredDayAverageChange": -7.61675, "twoHundredDayAverageChangePercent": -0.4197308, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1369229400000, "postMarketChangePercent": 0.876547, "postMarketPrice": 10.6223, "postMarketChange": 0.0923004, "regularMarketChange": 0.22999954, "regularMarketDayRange": "10.11 - 10.66", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 436995, "fiftyTwoWeekLowChange": 2.4899998, "fiftyTwoWeekLowChangePercent": 0.30970147, "fiftyTwoWeekRange": "8.04 - 45.0", "fiftyTwoWeekHighChange": -34.47, "fiftyTwoWeekHighChangePercent": -0.76600003, "fiftyTwoWeekChangePercent": -61.086475, "dividendDate": 1510790400, "corporateActions": [], "postMarketTime": 1744931193, "regularMarketTime": 1744920002, "exchange": "NGM", "messageBoardId": "finmb_235062181", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "displayName": "Arcturus Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]